IgA vasculitis with nephritis: update of pathogenesis with clinical implications-Reference-Cited by-同舟云学术

IgA vasculitis with nephritis: update of pathogenesis with clinical implications

Published:2021-04-05 Issue: Volume: Page:
ISSN:0931-041X
Container-title:Pediatric Nephrology
language:en
Short-container-title:Pediatr Nephrol

Author:

Hastings M. Colleen,Rizk Dana V.,Kiryluk Krzysztof,Nelson Raoul,Zahr Rima S.,Novak Jan,Wyatt Robert J.^ORCID

Funder

IGA Foundation of America

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Springer Science and Business Media LLC

Subject

Nephrology,Pediatrics, Perinatology and Child Health

Link

http://link.springer.com/content/pdf/10.1007/s00467-021-04950-y.pdf

Reference137 articles.

1. Heberden W (1806) Commentaries on the history and cure of diseases. London

2. Schönlein JL (1837) Allgemeine und Spezielle Pathologie und Therapie

3. Henoch E (1874) Über eine eigentümliche Form von Purpura. Berl Klin Wochenschr 11:641–643

4. Henoch E, in Herschward, A (ed): Vorlesungen uber kinderkranheiten, vol 10, Berlin, Aufl, p 839 (1899) Vorlesungen uber kinderkranheiten. In: Herschward A (ed) Vorlesungen uber kinderkranheiten, Berlin, pp Aufl, p 839

5. Davin JC, Coppo R (2014) Henoch-Schönlein purpura nephritis in children. Nat Rev Nephrol 10:563–573

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood soluble CD89-IgA complex may be a potential biomarker for predicting multi-organ involvement, especially renal involvement in children with immunoglobulin A vasculitis;International Immunopharmacology;2024-12

2. Preclinical Detection of Early Glomerular Injury in Children with Kidney Diseases—Independently of Usual Markers of Kidney Impairment and Inflammation;International Journal of Molecular Sciences;2024-08-28

3. Navigating Adult-Onset IgA Vasculitis-Associated Nephritis;Life;2024-07-25

4. Immunoglobulin A vasculitis: The clinical features and pathophysiology;The Kaohsiung Journal of Medical Sciences;2024-06-03

5. Sparsentan: the first and only non-immunosuppressive therapy for the reduction of proteinuria in IgA nephropathy;Expert Review of Clinical Immunology;2024-02-26